Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,564,500
-
Number of holders
-
138
-
Total 13F shares, excl. options
-
87,844,034
-
Shares change
-
+3,796,908
-
Total reported value, excl. options
-
$1,572,372,278
-
Value change
-
+$69,603,688
-
Put/Call ratio
-
62.07%
-
Number of buys
-
66
-
Number of sells
-
-64
-
Price
-
$17.9
Significant Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q3 2021
159 filings reported holding ATRA - Atara Biotherapeutics, Inc. - Common Stock as of Q3 2021.
Atara Biotherapeutics, Inc. - Common Stock (ATRA) has 138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 87,844,034 shares
.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (8,477,488 shares), JPMORGAN CHASE & CO (8,015,817 shares), MAVERICK CAPITAL LTD (7,855,824 shares), BlackRock Inc. (7,651,591 shares), VANGUARD GROUP INC (6,800,583 shares), Redmile Group, LLC (6,466,277 shares), FMR LLC (4,482,535 shares), STATE STREET CORP (3,780,897 shares), WASATCH ADVISORS INC (2,907,511 shares), and GOLDMAN SACHS GROUP INC (2,874,277 shares).
This table shows the top 138 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.